Genome-wide CRISPR/Cas9 Library Screening Identified TP53 As a Critical Driver for Resistance to EZH2 Inhibitor in Rhabdoid TumorsCeline Chauvin,Tiphaine Hery,Rachida Bouarich,Fariba Nemati,Diego Teyssonneau,Camille Fouassier, Chiara Giudiceandrea,Zhi-Yan Han,Sakina Zaidi,Didier Surdez,Sergio Roman-Roman,Didier Decaudin,Raphael Margueron,Franck BourdeautCANCER RESEARCH(2024)引用 0|浏览4AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要